anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Monroes Sequence

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 33,236
Current window 19,231-19,260
Pages 1,108
Rows per page 30
Arc: Monroes Sequenceclear collectionreset all
18 30 60

Arc

19,231-19,260 of 33,236

filter-aware
06
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
The slide serves as a visual index for the company's business units.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
12
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · SatisfactionLoop · Voice Of Customer1 hit
13
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · SatisfactionLoop · Voice Of Customer1 hit
14
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · SatisfactionLoop · Voice Of Customer1 hit
15
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · Action1 hit
16
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · Action1 hit
17
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · Action1 hit
18
The table includes a footnote clarifying the adjusted basis for specific segments.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · Action1 hit
19
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · Action1 hit
20
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Attention1 hit
02
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Attention1 hit
03
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Attention1 hit
04
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
05
Includes footnotes regarding non-GAAP reconciliation and royalty revenue impacts from Janssen license agreement.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
06
Includes a highlighted column for Q1'23 and detailed footnotes regarding product licensing and arbitration.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
07
The slide includes a disclaimer regarding the date of the expectations and a note about non-GAAP reconciliation.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
08
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
09
The chart illustrates the revenue contribution of four products: VIVITROL, ARISTADA, VUMERITY, and LYBALVI.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
10
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
11
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
12
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
13
The chart includes a vertical dashed line separating 2021 from 2022.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
14
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
15
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
16
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
17
The slide outlines a two-stage clinical development strategy with specific objectives and assessment criteria for each phase.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
18
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
19
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit